Clinical Cardiology
RSSArticles
-
Five-year EVEREST II Results Allay Long-term Safety and Durability Concerns About MitraClip
Although MitraClip patients had higher rates of re-operation in the first year, adverse event rates in the 1- to 5-year range were reassuringly low and were comparable with surgery.
-
Selecting Patients for Statin Primary Prevention
The new vascular disease risk calculator discriminates who will experience a vascular event in the near future better than using a trial entry criteria approach or a hybrid approach.
-
Blood Transfusion in Cardiac Disease Patients
In patients admitted to the ICU with comorbid cardiac disease, the hemoglobin level below which transfusion was associated with lower hospital mortality was < 8-9 g/dL and < 9-10 g/dL if the admitting diagnosis was acute myocardial infarction.
-
Is Sodium Restriction Detrimental in Chronic Heart Failure?
Dietary sodium restriction may have a detrimental effect on outcome in patients with symptomatic chronic heart failure. They stress that a randomized clinical trial is warranted to resolve the issue.
-
Echo Diagnosis of Left Ventricular Non-compaction
The echocardiographic diagnosis of left ventricular non-compaction is difficult, and experienced readers disagree frequently. Careful attention to suggested criteria and the use of other imaging modalities in difficult cases resolves most diagnostic disagreements.
-
FAME Data Shows Durability of Fractional Flow Reserve Strategy at 5 Years
The 5-year results of the FAME study did not show any late catch up in major adverse cardiac events in the fractional flow reserve-guided group, supporting the long-term safety of the fractional flow reserve-guided approach to percutaneous coronary interventions.
-
Management of Functional Mitral Regurgitation
In symptomatic patients with coronary artery disease, left ventricular ejection fraction < 30%, and significant mitral valve regurgitation, coronary bypass graft surgery (CABG) or CABG plus mitral valve repair should be considered.
-
Remote Hemodynamic Monitoring Shows Long-term Benefit in Heart Failure Patients
Remote pulmonary artery pressure monitoring in New York Heart Association class III heart failure patients resulted in fewer subsequent hospitalizations and was well tolerated.
-
Spironolactone for Resistant Hypertension
ABSTRACT & COMMENTARY: A study says spironolactone is superior to doxazosin and bisoprolol for lowering blood pressure.
-
Left Ventricular Assist Devices for Ambulatory Heart Failure: Weighing the Risks and Benefits
Recent data support the use of the HeartMate II left ventricular assist devices in functionally limited, non-inotrope-dependent heart failure patients who have poor quality of life and meet FDA criteria for destination therapy LVAD.